Cancer Research KI list of cancer research PIs across KI, C to G
Please find the cancer epidemiology, endocrine organ cancer, gastrointestinal tract cancer, general imaging within cancer and gynaecological organ cancer researchers at KI listed in the tables below.
Note that this is list is not complete and may still contain errors because the response rate on the conducted survey was below 100%. We would therefore like you to be in contact with us if you find that your name has been erroneously entered or if you would like to complete the current information in any way. Please send your update request to cancerresearchki@ki.se.
Cancer epidemiology research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Hans-Olov | Adami | hans-olov.adami@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | ||
| Agneta | Åkesson | Agneta.Akesson@ki.se | Institute of Environmental Medicine (IMM) | ||
| Olof | Akre | olof.akre@ki.se | Department of Molecular Medicine and Surgery (MMK) | 1. Prognostic markers in prostate cancer to tailor the right treatment based on better discrimination between potentially lethal and more indolent disease. 2. large academic clinical trial comparing surgery and radiotherapy in locally advanced prostate cancer3. Following up surgical cohorts for assessing risk of side effects and rare complications. | |
| Catarina | Almqvist Malmros | catarina.almqvist@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | ||
| Therese | Andersson | therese.andersson@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | Statistical methods for estimating cancer patient survival and population-based descriptive cancer epidemiology. Have worked with a range of cancer sites, especially hematology. | |
| Johan | Askling | johan.askling@ki.se | Department of Medicine, Solna (MedS) | ||
| Shahram | Bahmanyar | shahram.bahmanyar@ki.se | Department of Medicine, Solna (MedS) | ||
| Rino | Bellocco | rino.bellocco@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | ||
| Nele | Brusselaers | nele.brusselaers@ki.se | Department of Microbiology, Tumor and Cell Biology (MTC) | Effects of commonly prescribed drugs and the microbiome on the risk and survival of cancer. | |
| Kamila | Czene | kamila.czene@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | I am breast cancer epidemiologists. Main focus of my research is genetic and mammographic factors of breast cancer prognosis | |
| Paul | Dickman | paul.dickman@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | ||
| Gustaf | Edgren | gustaf.edgren@ki.se | Department of Medicine, Solna (MedS) | ||
| Sandra | Eloranta | sandra.eloranta@ki.se | Department of Medicine, Solna (MedS) | My main methodological interests are in statistical and epidemiological methods used for investigating population-based cancer patient survival and cancer survivorship issues, specifically in lymphoma. | https://ki.se/en/meds/kep-cancer-epidemiology-group |
| Fang | Fang | fang.fang@ki.se | Institute of Environmental Medicine (IMM) | I focus on the mental health consequences of cancer as well as the comorbidity between cancer and mental disorders. | https://ki.se/en/imm/unit-of-integrative-epidemiology |
| Sara | Hägg | sara.hagg@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | To find common pathways between aging and cancer development using large-scale epidemiological data. The main hypothesis is that accelerated biological aging is increasing the risk of cancer. | https://ki.se/en/meb/molecular-epidemiological-studies-of-aging-and-age… |
| Kent | Jardemark | Kent.Jardemark@ki.se | Department of Physiology and Pharmacology (Fyfa) | Effects of antibodies targeting KRAS | |
| Anna | Johansson | anna.johansson@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | Epidemiologist and biostatistician with research in register-based cancer epidemiology with a focus on integrating cancer survival methods with cancer quality registers. Population-based estimation of incidence and survival of breast cancer subtypes, as well as risks and outcomes of pregnancy-associated cancer. | |
| Mats | Lambe | mats.lambe@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | Epidemiological research based on population based registers | |
| Paul | Lambert | paul.lambert@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | ||
| Annika | Lindblom | annika.lindblom@ki.se | Department of Molecular Medicine and Surgery (MMK) | ||
| Caroline | Nordenvall | caroline.nordenvall@ki.se | Department of Molecular Medicine and Surgery (MMK) | Trying to explore clinical research questions regarding colorectal cancer patients using an epidemiological and translational approach. | https://ki.se/mmk/forskning-kolorektal-kirurgi |
| Olof | Nyren | olof.nyren@ki.se | Department of Medical Biochemistry and Biophysics (MBB) | ||
| Juni | Palmgren | juni.palmgren@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | ||
| Björn | Pasternak | bjorn.pasternak@ki.se | Department of Medicine, Solna (MedS) | Investigation of drug safety concerns where the outcome is cancer. Pharmacoepidemiology using register data. | |
| Marie | Reilly | marie.reilly@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | ||
| Unnur | Valdimarsdottir | unnur.valdimarsdottir@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) |
Childhood cancer
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Igor | Adameyko | igor.adameyko@ki.se | Department of Physiology and Pharmacology (Fyfa) | We do study neuroblastoma origin and heterogeneity | https://ki.se/en/fyfa/developmental-biology-and-regenerative-medicine |
| Marie | Arsenian-Henriksson | marie.arsenian.henriksson@ki.se | Department of Microbiology, Tumor and Cell Biology (MTC) | ||
| Ninib | Baryawno | n.baryawno@ki.se | Department of Women's and Children's Health (KBH) | Cancer and stem cell biology. Studying childhood cancers of the nervous system and bone metastases. | https://baryawnolab.com/ |
| Klas | Blomgren | klas.blomgren@ki.se | Department of Women's and Children's Health (KBH) | Our research is focused on injury and repair in the juvenile brain and we have found that the young, still growing brain reacts very differently to injury compared with an adult brain.We focus primarily on the type of injuries inflicted by ionizing radiation to the young brain, as used in the treatment of malignant diseases. | https://staff.ki.se/orgid/5206306 |
| Jan-Inge | Henter | Jan-Inge.Henter@ki.se | Department of Women's and Children's Health (KBH) | ||
| Nikolas | Herold | nikolas.herold@ki.se | Department of Women's and Children's Health (KBH) | My research is translational paediatric oncology whose basic research focuses on identification and characterization of resistance factors for combination chemotherapy and immunotherapy. The translational parts develops targeted strategies to overcome those resistance factors and submit them to early-phase clinical trials. | https://ki.se/en/kbh/translational-research-in-childhood-cancer |
| John Inge | Johnsen | john.inge.johnsen@ki.se | Department of Women's and Children's Health (KBH) | Translational research on pediatric neural tumors | https://ki.se/en/kbh/childhood-neural-tumor |
| Kasper | Karlsson | kasper.karlsson@scilifelab.se | Department of Oncology-Pathology (Onk-Pat) | We develop new experimental and computational tools to predict drug response that take intra-tumoral heterogeneity into account. We also investigate ways to improve radiation based therapies for pediatric cancers. | https://ki.se/en/onkpat/olli-kallioniemis-group |
| Per | Kogner | per.kogner@ki.se | Department of Women's and Children's Health (KBH) | ||
| Sonia | Lain | sonia.lain@ki.se | Department of Microbiology, Tumor and Cell Biology (MTC) | We have discovered potent and specific small molecule inhibitors that are currently being developed for the treatment of cancer. At present we are working on identifying agents to remove/inhibit enzymes that accumulate in plasma during ageing and disease, including metastatic cancer. | |
| Karin | Larsson | karin.larsson@ki.se | Department of Medicine, Solna (MedS) | Investigations of the role of mPGES-1/PGE2 in tumor progression and treatment resistance. | https://ki.se/en/meds/research-group-per-johan-jakobsson |
| Anna | Nilsson | anna.nilsson.1@ki.se | Department of Women's and Children's Health (KBH) | Adaptive immunity in children with cancer. Effects of chemo on normal lymphocytes | https://medarbetare.ki.se/orgid/5206307 |
| Pernilla | Pergert | pernilla.pergert@ki.se | Department of Women's and Children's Health (KBH) | We perform childhood cancer healthcare research, focusing on intercultural care & clinical ethics. | https://ki.se/en/kbh/childhood-cancer-healthcare-research |
| Susanne | Schlisio | susanne.schlisio@ki.se | Department of Microbiology, Tumor and Cell Biology (MTC) | Why are advanced cancers eventually acquiring resistance to targeted therapies and relapse? What are the causes of clinical heterogeneity and outcome in high-risk childhood neuroblastoma.How do we cope with oxygen deprivation (hypoxia) in health and disease? | https://ki.se/en/mtc/schlisio-lab |
| Malin | Wickström | malin.wickstrom@ki.se | Department of Women's and Children's Health (KBH) | Novel therapies for treatment of neuroblastoma. | https://staff.ki.se/orgid/52063018 |
| Ourania | Kostopoulou | ourania.kostopoulou@ki.se | Department of Oncology-Pathology (Onk-Pat) | Studies on novel and optimized combinations of targeted therapies in neuroblastoma and medulloblastoma. | https://ki.se/en/onkpat/research-team-ourania-kostopoulou |
Endocrine organ cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Christofer | Juhlin | christofer.juhlin@ki.se | Department of Oncology-Pathology (Onk-Pat) | Molecular genetic studies of endocrine tumors for implementation in clinical routine practice. | https://ki.se/en/onkpat/research-team-christofer-juhlin |
| Catharina | Larsson | catharina.larsson@ki.se | Department of Oncology-Pathology (Onk-Pat) | Molecular, functional and clinical aspects of endocrine tumor development | https://ki.se/en/onkpat/research-team-catharina-larsson |
| Jan | Zedenius | jan.zedenius@ki.se | Department of Molecular Medicine and Surgery (MMK) | We look for prognostic factors in endocrine tumors, with the aim to individualize and optimize treament. |
Gastrointestinal tract cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Lauri | Aaltonen | lauri.aaltonen@ki.se | Department of Biosciences and Nutrition (BioNut) | Tumor genetics. Functional analyses of novel mutations/genetic aberrations that have been linked to colorectal cancer, to explore how these contribute to tumourigenesis. | |
| Hans | Grönlund | hans.gronlund@ki.se | Department of Clinical Neuroscience (CNS) | I have taken a patented idea from the lab bench to a valid application to the Swedish MPA with CRC as first indication. The treatment is an ACT, cancer agnostic, in collaboration with Vecura, CTC, CAST, and clinical trial center NKS, Västerås hospital | https://neogap.se/ |
| Ulf | Gustafsson | ulf.gustafsson@ki.se | Department of Clinical Sciences, Danderyd Hospital | ||
| Torbjörn | Holm | torbjorn.holm@ki.se | Department of Clinical Science and Education, Södersjukhuset | ||
| Rolf | Hultcrantz | rolf.hultcrantz@ki.se | Department of Medicine, Solna (MedS) | Colorectal cancer screening | |
| Magnus | Ingelman-Sundberg | magnus.ingelman-sundberg@ki.se | Department of Physiology and Pharmacology (Fyfa) | ||
| Pekka | Katajisto | pekka.katajisto@ki.se | Department of Cell and Molecular Biology (CMB) | We study the early steps of tumor initiation in the gastrointestinal tract. | https://www.katajisto-lab.com/ |
| Jesper | Lagergren | jesper.lagergren@ki.se | Department of Molecular Medicine and Surgery (MMK) | Aetiology of oesophageal and gastric cancer and associated conditions. Treatment (mainly surgical) of oesophageal and gastric cancer and associated conditions. | https://ki.se/en/mmk/upper-gi-surgery |
| Mats | Lindblad | mats.lindblad@ki.se | Department of Clinical Science, Intervention and Technology (ClinTec) | I am studying effects of, and reasons for, regional differences in given care for oesophageal and gastric cancer in Sweden | |
| Matthias | Löhr | matthias.lohr@ki.se | Department of Clinical Science, Intervention and Technology (ClinTec) | My work is focussed on pancreatic cancer, preclinical, translational, and clinical, including biomarkers and precision medicine. I have an interest in preneoplastic lesions (IPMN) and individuals at risk for hereditary cancer syndromes. | |
| Jonas | Ludvigsson | jonas.ludvigsson@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) | ||
| Anna | Martling | anna.martling@ki.se | Department of Molecular Medicine and Surgery (MMK) | ||
| Jenny | Mjösberg | jenny.mjosberg@ki.se | Department of Medicine, Huddinge (MedH) | We study intratumoral lymphocytes in colorectal cancer (CRC) and CRC-related peritoneal carcinomatosis (PC). To this end we are performing multidimensional single-cell analysis of proteins and transcripts in intratumoral innate lymphoid cells (ILCs) and T cells to reveal the characteristics, heterogeneity and functional parallels between ILCs and T cells which will advance our understanding of anti-tumor immunity in CRC and CRC+PC. | https://mjosberglab.wixsite.com/ilcs |
| Erik | Näslund | erik.naslund@ki.se | Department of Clinical Sciences, Danderyd Hospital | ||
| Magnus | Nilsson | magnus.nilsson@ki.se | Department of Clinical Science, Intervention and Technology (ClinTec) | Clinical and translational research focused on esophageal and gastric cancer. The group runs several international academic randomized trials in the field. Biobanking and molecular tumor profiling both within the trials and in separate study settings is a focus area of the group. | |
| Caroline | Nordenvall | caroline.nordenvall@ki.se | Department of Molecular Medicine and Surgery (MMK) | Research in colorectal surgery with focus on colorectal cancer end inflammatory bowel disease. | https://ki.se/mmk/kolorektal-kirurgi |
| Magdalena | Paolino | magdalena.paolino@ki.se | Department of Medicine, Solna (MedS) | We study the role of ubiquitin-dependent pathways in cancer initiation, progression and metastasis. We explore its effects both at the level of the cancer cell as well as in the immune system anti-tumor responses. | https://ki.se/en/meds/team-magdalena-paolino |
| Josefin | Segelman | josefin.segelman@ki.se | Department of Molecular Medicine and Surgery (MMK) | ||
| Cecilia | Williams | cecilia.williams@ki.se | Department of Biosciences and Nutrition (BioNut) | The role of hormones for cancer development and progression. Protective role in colorectal cancer, and related sex differences. | https://ki.se/en/bionut/hormone-signalling-and-non-coding-rnas-in-cance… |
General imaging, cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Staffan | Holmin | staffan.holmin@ki.se | Department of Clinical Neuroscience (CNS) | ||
| Sharon | Stone-Elander | sharon.stone-elander@ki.se | Department of Clinical Neuroscience (CNS) | ||
| Thuy | Tran | thuy.tran@ki.se | Department of Oncology-Pathology (Onk-Pat) | Our group develop novel radiopharmaceuticals for theranostics, including cyclotron production of exotic radiometals using solid target, evaluation studies in vitro and in vivo to clinical translation. We provide services in GMP manufacturing of radiopharmaceuticals (based on PET-emitting, SPECT-emitting radionuclides and therapeutic emitters such as 225Ac, 177Lu) for first-in-man and phase I/II/III studies. | https://ki.se/en/onkpat/research-team-thuy-tran |
| Renske | Altena | renske.altena@ki.se | Department of Oncology-Pathology (Onk-Pat) | Molecular imaging of treatment targets new PET-tracers in different cohorts of patients with metastatic solid tumors. Development of therapeutic radioisotopes and early phase clinical trials. |
Gynecological organ cancer research
| First Name | Surname | KI email | Department | Description | Group website |
|---|---|---|---|---|---|
| Joseph | Carlson | joseph.carlson@ki.se | Department of Oncology-Pathology (Onk-Pat) | ||
| Joakim | Dillner | joakim.dillner@ki.se | Department of Laboratory Medicine (LabMed) | My research focuses on cervical cancer prevention, such as optimization of the gynecological cell sampling program through mathematical modelling as well as finding new biomarkers. | https://ki.se/en/labmed/research-group-joakim-dillner |
| Henrik | Falconer | henrik.falconer@ki.se | Department of Women's and Children's Health (KBH) | "1. Clinical research in Gynecologic Oncology2. Epidemiological research gynecologic cancer" | |
| Matti | Lehtinen | matti.lehtinen@ki.se | Department of Laboratory Medicine (LabMed) | ||
| Miriam | Mints | miriam.mints@ki.se | Department of Women's and Children's Health (KBH) | ||
| Maria | Shoshan | mimmi.shoshan@ki.se | Department of Oncology-Pathology (Onk-Pat) | ||
| Pär | Sparen | par.sparen@ki.se | Department of Medical Epidemiology and Biostatistics (MEB) |